Distribution of tetracycline resistance genes tet(M), tet(O), tet(L) and tet(K) in blood isolates of viridans group streptococci harbouring erm(B) and mef(A) genes. Susceptibility to quinupristin/dalfopristin and linezolid

International Journal of Antimicrobial Agents

Volumn 21, Issue 6, 2003, Pages 536-541

  Rodriguez Avial, Iciar ^a   Rodriguez Avial, Carmen ^a   Culebras, Esther ^a   Picazo, Juan J ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Linezolid; Macrolide resistance determinants; Quinupristin dalfopristin; Tetracycline resistance determinants; Viridans streptococci

Indexed keywords

CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; LINEZOLID; TETRACYCLINE;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BLOOD CULTURE; CONTROLLED STUDY; DRUG SENSITIVITY; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0037844853     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(03)00062-1     Document Type: Article

References (33)

1. Awada G., Van der Auwera P., Meunier F., Daneau D., Klastersky J. Streptococcal and enterococcal bacteria in patients with cancer. Clin. Infect. Dis. 15:1992;33-48.
2. Bochud P.Y., Calandra T., Francioli P. Bacteremia due to viridans streptococci in neutropenic patients: a review. Am. J. Med. 97:1994;256-264.
3. Carratalá J., Alcaide F., Fernández-Sevilla A., Corbella X., Liñares J., Gudiol F. Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer. Clin. Infect. Dis. 20:1995;1169-1173.
4. Doern G.V., Ferraro M.J., Brueggemann A.B., Ruoff K.L. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob. Agents Chemother. 40:1996;891-894.
5. Alcaide F., Carratalá J., Liñares J., Gudiol F., Martín R. In vitro activities of eight macrolide antibiotics and RP-59.500 (quinupristin-dalfopristin) against viridans group streptococci isolates from blood of neutropenic cancer patients. Antimicrob. Agents Chemother. 40:1996;2117-2120.
6. Wisplinghoff H., Reinert R.R., Cornely O., Seifert H. Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients. J. Clin. Microbiol. 37:1999;1876-1880.
7. Diekema D.J., Beach M.L., Pfaller M.A., Jones R.N. Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America. Clin. Microb. Infect. 7:2001;152-157.
8. Alcaide F., Benítez M.A., Carratalá J., Gudiol F., Liñares J., Martín R. In vitro activities of the new ketolide HMR3647 (telithromycin) in comparison with those of eight other antibiotics against viridans group streptococci isolated from blood of neutropenic patients with cancer. Antimicrob. Agents Chemother. 45:2001;624-626.
9. Clancy J., Petipas J., Dib-Hajj F., et al. Molecular cloning and functional analysis of a novel macrolide-resistance determinant mef A from Streptococcus pyogenes. Mol. Microbiol. 22:1996;867-879.
10. Sutcliffe J., Tait-Kamradt A., Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by efflux system. Antimicrob. Agents Chemother. 40:1996;1817-1824.
11. Chopra I., Hawkey P.M., Hinton M. Tetracyclines, molecular and clinical aspects. J. Antimicrob. Chemother. 29:1992;245-277.
12. Roberts M.C., Hillier S.L. Genetic basis of tetracycline resistance in urogenital bacteria. Antimicrob. Agents Chemother. 34:1990;261-264.
13. Roberts M.C., Chung W.O., Roe D.E. Characterization of tetracycline and erythromycin resistance determinants in Treponema denticola. Antimicrob. Agents Chemother. 40:1996;1690-1694.
14. Poyart-Salmeron C., Trieu-Cuot P., Carlier C., Courvalin P. Nucleotide sequence specific for Tn 1545-like conjugative transposons in pneumococci and staphylococci resistant to tetracycline. Antimicrob. Agents Chemother. 35:1991;1657-1660.
15. Courvalin P., Carlier C. Transposable multiple antibiotic resistance in Streptococcus pneumoniae. Mol. Gen. Genet. 205:1986;291-297.
16. Kataja J., Seppälä H., Skurnik M., Sarkkinen H., Huovinen P. Different erythromycin resistance mechanisms in group C and group G streptococci. Antimicrob. Agents Chemother. 42:1998;1493-1494.
17. Culebras E., Rodríguez-Avial I., Betriú C., Redondo M., Picazo J.J. Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae. Antimicrob. Agents Chemother. 46:2002;1574-1576.
18. Teng L.J., Hsueh P.R., Ho S.W., Luh K.T. High prevalence of inducible erythromycin resistance among Streptococcus bovis isolates in Taiwan. Antimicrob. Agents Chemother. 45:2001;3362-3365.
19. Livermore D.M. Quinupristin/dalfopristin and linezolid: where, when, which and whether to use. J. Antimicrob. Chemother. 46:2000;347-350.
20. Johnson A.P., Warner M., Livermore D.M. Activity of linezolid against multi-resistant Gram-positive bacteria from diverse hospitals in the United Kingdom. J. Antimicrob. Chemother. 45:2000;225-230.
21. Kennedy H.F., Gemmell C.G., Bagg J., Gibson B.E.S., Michie J.R. Antimicrobial susceptibility of blood culture isolates of viridans streptococci: relationship to a change in empirical antibiotic therapy in febrile neutropenia. J. Antimicrob. Chemother. 47:2001;693-696.
22. Ruoff K.L. Streptococcus. Murray P.R., Baron E.J., Pfayer M.A., Tenover F.C., Yolken R.H. Manual of clinical microbiology. 6th ed: 1995;American Society for Microbiology, Washington, DC.
23. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically; approved standard, M7-A5. 2000;National Committee for Clinical Laboratory Standards, Wyne, PA.
24. Chung W.O., Werckenthin C., Shwarz S., Roberts M.C. Host range of ermF rRNA methylase gene in bacteria of human and animal origin. J. Antimicrob. Chemother. 43:1999;5-14.
25. Sutciffe J., Grebe T., Tait-Kamradt A., Wondrack L. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:1996;2562-2566.
26. Seppälä H., Skurnik M., Soini H., Roberts M.C., Huovinen P. A novel erythromycin methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob. Agents Chemother. 42:1998;257-262.
27. Trzcinski K., Cooper B.S., Hryniewicz W., Dowson C.G. Expression of resistance to tetracyclines in strains of methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 45:2000;763-770.
28. Gershon A.S., de Azavedo J.C.S., McGeer A., et al. Activities of new fluoroquinolones, ketolides and other antimicrobials against blood culture isolates of viridans group streptococci from across Canada. Antimicrob. Agents Chemother. 46:2002;1553-1556.
29. pC194 and the integrase gene of Tn1545 in clinical Streptococcus pneumoniae harbouring erm(B) and mef(A) genes in Spain. J. Antimicrob. Chemother. 47:2001;863-866.
30. Jacobs J.A., van Baar G.J., London N.H.H.J., Tjhie J.H.T., Schouls L.M., Stobberingh E.E. Prevalence of macrolide resistance genes in clinical isolates of the Streptococcus anginosus (S. milleri) group. Antimicrob. Agents Chemother. 45:2000;2375-2377.
31. Luna V.A., Roberts M.C. The presence of the tet(O) gene in a variety of tetracycline-resistant Streptococcus pneumoniae serotypes from Washington state. J. Antimicrob. Chemother. 42:1998;613-619.
32. Mouton J.W., Endtz H.P., den Hollander J.G., van den Brak N., Berbrugh H.A. In vitro activity of quinupristin/dalfopristin compared with other widely used antibiotics against strains isolated from patients with endocarditis. J. Antimicrob. Chemother. 39:1997;75-80.
33. Cercenado E., García-Garrote F., Bouza E. In vitro activity of linezolid against multiply resistant Gram-positive clinical isolates. J. Antimicrob. Chemother. 47:2001;77-81.